Champions Oncology outlines fiscal 2027 plan with Corellia fully funded as it reports $59.4M revenue and $1.6M adjusted EBITDA (NASDAQ:CSBR)July 27, 2026
Share Facebook Twitter LinkedIn Pinterest Email Goldman Sachs GAAP EPS of $17.55 beats by $1.16, revenue of $17.23B beats by $300M
Champions Oncology outlines fiscal 2027 plan with Corellia fully funded as it reports $59.4M revenue and $1.6M adjusted EBITDA (NASDAQ:CSBR)July 27, 2026
By Press Room
By Press Room
By Press Room
